Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma

Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Investig Med High Impact Case Rep
Main Authors: Kichloo, Asim, Albosta, Michael S., McMahon, Shane, Movsesian, Kimberly, Wani, Farah, Jamal, Shakeel M., Aljadah, Michael, Singh, Jagmeet
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448133/
https://ncbi.nlm.nih.gov/pubmed/32830561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709620951339
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki